Osmotic therapies added to antibiotics for acute bacterial meningitis

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 2, 2018, Pages

  Wall, Emma C B ^a   Ajdukiewicz, Katherine M B ^b   Bergman, Hanna ^c   Heyderman, Robert S ^d   Garner, Paul ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c Cochrane Response ^*  (United Kingdom)

^d UNIVERSITY OF MALAWI   (Malawi)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; GLUCOSE; GLYCEROL; OSMOTIC AGENT; OSMOTIC DIURETIC AGENT; PARACETAMOL; PLACEBO; STEROID; ANTIINFECTIVE AGENT; CORTICOSTEROID;

ACUTE DISEASE; BACTERIAL MENINGITIS; BRAIN DAMAGE; CEREBROSPINAL FLUID; CHEMICAL MODIFICATION; CLINICAL EFFECTIVENESS; DEATH; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; GASTROINTESTINAL HEMORRHAGE; HEARING IMPAIRMENT; HIGH INCOME COUNTRY; HUMAN; LONG TERM CARE; LOW INCOME COUNTRY; MORTALITY RATE; NAUSEA; NEUROLOGIC DISEASE; OSMOTIC PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEIZURE; SPINAL CORD; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING; ADOLESCENT; ADULT; CHILD; COMMUNITY ACQUIRED INFECTION; COMPLICATION; EPILEPSY; INTRACRANIAL PRESSURE; META ANALYSIS; METABOLISM; MORTALITY; MULTIMODALITY CANCER THERAPY; OSMOSIS; PHYSIOLOGY; PROCEDURES;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; CHILD; COMBINED MODALITY THERAPY; COMMUNITY-ACQUIRED INFECTIONS; DEAFNESS; DEXAMETHASONE; DIURETICS, OSMOTIC; EPILEPSY; GASTROINTESTINAL HEMORRHAGE; GLUCOSE; GLYCEROL; HUMANS; INTRACRANIAL PRESSURE; MENINGITIS, BACTERIAL; NERVOUS SYSTEM DISEASES; OSMOSIS; OSMOTIC PRESSURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85041646311     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008806.pub3     Document Type: Review

References (68)

1. Ajdukiewicz KM. Glycerol adjuvant therapy in adult bacterial meningitis in Malawi [MD thesis]. Liverpool (UK): University of Liverpool, 2012. 3055077
2. Ajdukiewicz KM, Cartwright KE, Scarborough M, Mwambene JB, Goodson P, Molyneux ME, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infectious Diseases 2011;11(4):293-300. 3055076
3. Kilpi T, Peltola H, Jauhiainen T, Kallio MJ. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatric Infectious Disease Journal 1995;14(4):270-8. 3055079
4. Molyneux EM, Kawaza K, Phiri A, Chimalizeni Y, Mankhambo L, Schwalbe E, et al. Glycerol and acetaminophen as adjuvant therapy did not affect the outcome of bacterial meningitis in Malawian children. Pediatric Infectious Disease Journal 2014;33(2):214-6. 7539550
5. Peltola H, Roine I, Fernandez J, Gonzlez MA, Zavala I, Gonzalez A, et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Paediatrics 2010;125(1):e1-8. 7539551
6. Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases 2007;45(10):1277-86. 3055085
7. Sankar J, Singhi P, Bansal A, Ray P, Singhi S. Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatrics 2007;44(9):649-56. 3055087
8. Singhi S, Järvinen A, Peltola H. Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatric Infectious Diseases Journal 2008;27(10):892-6. 7539552
9. Almirante B, Cortés E, Pigrau C, Gasser I, del Valle O, Campos L, et al. Therapy and outcome of pneumococcal meningitis in adults. A recent series of 70 episodes. Medicina Clinica 1995;105(18):681-6. 7539554
10. CTRI/2015/04/005668. Oral glycerol in newborn brain infections [Randomized comparison of oral glycerol and standard treatment versus standard treatment alone in management of neonatal bacterial meningitis]. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=11180 (first received 7 April 2015). 7539556
11. Glimåker M, Johansson B, Halldorsdottir H, Wanecek M, Elmi-Terander A, Ghatan PH, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PloS One 2014;9(3):e91976. 7539558
12. Herson VC, Todd JK. Prediction of morbidity in Hemophilus influenzae meningitis. Pediatrics 1977;59(1):35-9. 3055091
13. CTRI/2012/05/002650. The effects of cerebral perfusion pressure and intracranial pressure targeted therapy in children with raised intracranial pressure and acute central nervous system infections [A pilot study to compare the outcome of CPP targeted therapy versus ICP targeted therapy in children with acute meningitis]. ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=4595 (first received 14 May 2012). 7539560
14. Kumar R, Singhi S, Singhi P, Jayashree M, Bansal A, Bhatti A. Randomized controlled trial comparing cerebral perfusion pressure-targeted therapy versus intracranial pressure-targeted therapy for raised intracranial pressure due to acute CNS infections in children. Critical Care Medicine 2014;42(8):1775-87. 7539561
15. Molyneux E, Njiram'madzi J. Prevention and treatment of bacterial meningitis in resource poor settings. Pediatric Infectious Disease Journal 2015;34(4):441-3. 7539563
16. Pecco P, Pavesio D, Peisino MG. Rational basis of modern therapy of bacterial meningitis. Review of the literature and our clinical experience of 122 pediatric cases. Panminerva Medica 1991;33(4):185-90. 3055093
17. Pelegrin I, Verdaguer R, Ariza J, Viladrich PF, Cabellos C. Effect of adjuvant therapy in pneumococcal meningitis: seizures and mortality. Clinical Microbiology and Infection 2012;19(Suppl):834. 3055095
18. Peltola H, Leib SL. Performance of adjunctive therapy in bacterial meningitis depends on circumstances. Pediatric Infectious Disease Journal 2013;32(12):1381-2. 7539565
19. Singhi S, Khetarpal R, Baranwal AK, Singhi PD. Intensive care needs of children with acute bacterial meningitis: a developing country perspective. Annals of Tropical Paediatrics 2004;24(2):133-40. 3055099
20. Singhi S, Singhi P. Glycerol and dexamethasone in bacterial meningitis in low-income countries: response to the editorial commentary. Clinical Infectious Diseases 2007;47(5):732-3. 3055101
21. Urciuoli R. A new osmotic drug: hypertonic solution of mannitol. Advantages as compared with urea. Use in the treatment of aseptic serous meningitis and postoperative cerebrospinal fluid fistulas. Gazzetta Medica Italiana 1963;122:234-6. 3055105
22. Vaziri S, Mansouri F, Sayad B, Ghadiri K, Torkashvand E, Rezaei M, et al. Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis. Journal of Research in Medical Sciences 2016;21(2):8. 7539567
23. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
24. Bereczki D, Liu M, Fernandes do Prado G, Fekete I. Mannitol for acute stroke. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD001153.pub2]
25. Blaser C, Klein M, Grandgirard D, Wittwer M, Peltola H, Weigand M, et al. Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis. BMC Infectious Diseases 2010;10:84.
26. Brouwer M, van de Beek D. Glycerol in bacterial meningitis: one strike and out?. Lancet Infectious Diseases 2011;11(4):257-8.
27. Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD004405.pub5]
28. Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Initial management. Journal of Neurotrauma 2000;17(6-7):463-9.
29. Choi CW, Hwang JH, Chang JS, Park WS, Kim BI, Choi JH, et al. Effects of hypertonic (7%) saline on brain injury in experimental Escherichia coli meningitis. Journal of Korean Medical Science 2005;20(5):870-6.
30. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. New England Journal of Medicine 2002;347(20):1549-56.
31. Domingo P, Suarez-Lozano I, Torres F, Pomar V, Ribera E, Galindo MJ, et al. Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2009;51(5):582-7.
32. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 6 September 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
33. Harnden A, Ninis N, Thompson M, Perera R, Levin M, Mant D, et al. Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study. BMJ (Clinical Research ed.) 2006;332(7553):1295-8.
34. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
35. Ichai C, Armando G, Orban JC, Berthier F, Rami L, Samat-Long C, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Medicine 2009;35(3):471-9.
36. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from www.handbook.cochrane.org 2011.
37. Maconochie IK, Baumer JH. Fluid therapy for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD004786.pub5]
38. Mahdi LK, Wang H, Van der Hoek M, Paton JC, Ogunniyi AD. Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice. Journal of Clinical Investigation 2012;122(6):2208-20.
39. Mathew NT, Rivera VM, Meyer JS, Charney JZ, Hartmann A. Double-blind evaluation of glycerol therapy in acute cerebral infarction. Lancet 1972;2(7791):1327-9.
40. McCormick DW, Wilson ML, Mankhambo L, Phiri A, Chimalizeni Y, Kawaza K, et al. Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010. Pediatric Infectious Diseases Journal 2012;32(2):e54-61.
41. Meyer JS, Teraura T, Marx P, Hashi K, Sakamoto K. Brain swelling due to experimental cerebral infarction. Changes in vasomotor capacitance and effects of intravenous glycerol. Brain 1972;95(4):833-52.
42. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360(9328):211-8.
43. Molyneux E, Riordan FA, Walsh A. Acute bacterial meningitis in children presenting to the Royal Liverpool Children's Hospital, Liverpool, UK and the Queen Elizabeth Central Hospital in Blantyre, Malawi: a world of difference. Annals of Tropical Paediatrics 2006;26(1):29-37.
44. Namutangula B, Ndeezi G, Byarugaba JS, Tumwine JK. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malaria Journal 2007;6:138.
45. Nguyen TH, Tran TH, Thwaites G, Ly VC, Dinh XS, Ho Dang TN, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. New England Journal of Medicine 2007;357(24):2431-40.
46. Okoromah CAN, Afolabi BB, Wall ECB. Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD004615.pub3]
47. Pelkonen T, Roine I, Monteiro L, Correia M, Pitkaranta A, Bernardino L, et al. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clinical Infectious Diseases 2009;48(8):1107-10.
48. Peltola H, Roine I. Improving the outcomes in children with bacterial meningitis. Current Opinion in Infectious Diseases 2009;22(3):250-5.
49. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
50. Righetti E, Celani MG, Cantisani TA, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD000096.pub2]
51. Roine I, Saukkoriipi A, Leinonen M, Peltola H. Microbial genome count in cerebrospinal fluid compared with clinical characteristics in pneumococcal and Haemophilus influenzae type B meningitis in children. Diagnostic Microbiology Infectious Diseases 2009;63(1):16-23.
52. Saez-Llorens X, McCracken GH Jr. Glycerol and bacterial meningitis. Clinical Infectious Diseases 2007;45(10):1287-9.
53. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. New England Journal of Medicine 2007;357(24):2441-50.
54. Schmidt H, Stuertz K, Chen V, Stringaris AK, Bruck W, Nau R. Glycerol does not reduce neuronal damage in experimental Streptococcus pneumoniae meningitis in rabbits. Inflammopharmacology 1998;6(1):19-26.
55. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002;33(1):136-40.
56. Singhi S, Järvinen A, Peltola H. Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis. Pediatric Infectious Diseases Journal 2008;27(10):892-6.
57. Stoll J, Hagen M, Bartylla T, Weber K, Jost M, Treib V. Changes of cerebral perfusion after osmotherapy in acute cerebral edema assessed with perfusion weighted MRI. Neurological Research 1998;20(6):474-8.
58. Sudarsanam TD, Rupali P, Tharyan P, Abraham OC, Thomas K. Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database of Systematic Reviews 2017, Issue 6. [DOI: 10.1002/14651858.CD005437.pub4]
59. United Nations Development Programme. Human Development Report. hdr.undp.org/en/reports/global/hdr2009/ (accessed prior to 13 September 2017).
60. van de Beek D. Corticosteroids for acute adult bacterial meningitis. Medical Maladies Infectieuse 2009;39(7-8):531-8.
61. van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurology 2010;9(3):254-63.
62. van Well GT, Sanders MS, Ouburg S, van Furth AM, Morré SA. Polymorphisms in toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis. PLoS One 2012;7(5):e35837.
63. Wakai A, McCabe A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD001049.pub5]
64. Wall EC, Mukaka M, Scarborough M, Ajdukiewicz KMA, Cartwright KE, Nyirenda M, et al. Prediction of outcome from adult bacterial meningitis in a high-HIV-seroprevalence, resource-poor setting using the Malawi Adult Meningitis Score (MAMS). Clinical Infectious Diseases 2017;64(4):413-9.
65. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 1992;23(7):967-71.
66. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, et al. Treatment of acute cortical infarct with intravenous glycerol. A double-blind, placebo-controlled randomized trial. Stroke 1993;24(8):1119-24.
67. Wall ECB, Ajdukiewicz KMB, Heyderman RS, Garner P. Osmotic therapies as adjuncts to antibiotics for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2010, Issue 11. [DOI: 10.1002/14651858.CD008806]
68. Wall ECB, Ajdukiewicz KMB, Heyderman RS, Garner P. Osmotic therapies added to antibiotics for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD008806.pub2]